Docetaxel (DTX) plus cisplatin (CDDP) in locally advanced or metastatic head and neck cancer (HN). A phase II study.

被引：0
|
作者：
Caponigro, F
Avallone, A
Rivellini, F
Sguotti, C
Manzione, L
De Lucia, L
Biglietto, M
Massa, E
Comella, P
Mantovani, G
Comella, G
机构：
[1] Natl Tumor Inst Naples, So Italy Cooperat Oncol Grp, Naples, Italy
[2] Rhone Poulenc Rorer, Orrigio, Italy
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
218
引用
收藏
页码：3773S / 3773S
页数：1
相关论文
共 50 条
  • [1] Docetaxel (DTX) plus cisplatin (CDDP) in locally advanced or metastatic head and neck cancer (HN). A phase II study
    Caponigro, F
    De Lucia, L
    Biglietto, M
    Avallone, A
    Rivellini, F
    Sguotti, G
    Manzione, L
    Comella, P
    Mantovani, G
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S168 - S168
  • [2] A phase I-II study of cisplatin (CDDP) plus tomudex (TOM) plus levofolinic acid (LFA) plus 5-fluorouracil (5-FU) in locally advanced or metastatic head and neck cancer (HN).
    Caponigro, F
    Budillon, A
    Avallone, A
    Rivellini, F
    Di Gennaro, E
    Ionna, F
    Mozzillo, N
    Marcolin, P
    Guida, C
    Comella, P
    Comella, G
    CLINICAL CANCER RESEARCH, 1999, 5 : 3775S - 3775S
  • [3] Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer
    Guntinas-Lichius, O
    Appenrodt, S
    Veelken, F
    Krug, B
    LARYNGOSCOPE, 2006, 116 (04): : 613 - 618
  • [4] A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer
    Lee, Ji Yun
    Sun, Jong-Mu
    Oh, Dongryul
    Lim, Sung Hee
    Chi, Sangah
    Lee, Se-Hoon
    Jung, Sin-Ho
    Ahn, Myung-Ju
    Ahn, Yong Chan
    Park, Keunchil
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) : 217 - 223
  • [5] A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
    Fury, Matthew G.
    Sherman, Eric
    Ho, Alan L.
    Xiao, Han
    Tsai, Frank
    Nwankwo, Oby
    Sima, Camelia
    Heguy, Adrian
    Katabi, Nora
    Haque, Sofia
    Pfister, David G.
    CANCER, 2013, 119 (10) : 1823 - 1831
  • [6] Phase II study of bavituximab plus docetaxel in locally advanced or metastatic breast cancer
    Tabagari, D.
    Nemsadze, G.
    Janjalia, M.
    Jincharadze, M.
    Shan, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Docetaxel plus platinum combination regimen in locally advanced or metastatic head and neck cancer
    Kucukzeybek, Yuksel
    Gorumlu, Gurbuz
    Karabulut, Bulent
    Uslu, Ruchan
    Sanli, Ulus A.
    Goker, Erdem
    ANNALS OF ONCOLOGY, 2006, 17 : 187 - 187
  • [8] Weekly chemotherapy with cisplatin and docetaxel for recurrent metastatic head and neck cancer: a phase II study
    Guntinas-Lichius, O.
    Appenrodt, S.
    Veelken, F.
    Krug, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 297 - 297
  • [9] A phase II study of simultaneous radiochemotherapy with cisplatin (cDDP) and tegafur in advanced head and neck cancer (AHNC)
    De la Torre, A
    Romero, J
    Regueiro, CA
    Valcarcel, F
    Magallón, R
    Bernal, T
    Martín, M
    Peiró, A
    Montero, A
    Aragón, G
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 927 - 931
  • [10] Concurrent chemoradiotherapy with weekly docetaxel and cisplatin for locally advanced head and neck cancer: Phase I study
    Kim, H. S.
    Park, K.
    Ahn, M. J.
    Park, Y.
    Lee, S.
    Baek, C.
    Son, Y.
    Jeong, H.
    Ahn, Y.
    Park, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345